{"id":29232,"date":"2020-07-16T09:54:24","date_gmt":"2020-07-16T09:54:24","guid":{"rendered":"https:\/\/www.healthbenefitstimes.com\/glossary\/?p=29232"},"modified":"2020-07-16T09:54:24","modified_gmt":"2020-07-16T09:54:24","slug":"ropinirole","status":"publish","type":"post","link":"https:\/\/www.healthbenefitstimes.com\/glossary\/ropinirole\/","title":{"rendered":"Ropinirole"},"content":{"rendered":"<p>A dopamine agonist drug indicated for the treatment of the signs and symptoms of idiopathic parkinson\u2019s disease and of moderate to severe primary restless legs syndrome. Marketed under the brand name requip.<\/p>\n<hr \/>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>A dopamine agonist drug indicated for the treatment of the signs and symptoms of idiopathic parkinson\u2019s disease and of moderate to severe primary restless legs syndrome. Marketed under the brand name requip. &nbsp;<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[18],"tags":[],"class_list":["post-29232","post","type-post","status-publish","format-standard","hentry","category-r"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v21.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Ropinirole - Definition of Ropinirole<\/title>\n<meta name=\"description\" content=\"A dopamine agonist drug indicated for the treatment of the signs and symptoms of idiopathic parkinson\u2019s disease and of moderate to severe primary restless legs syndrome. Marketed under the brand name requip.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.healthbenefitstimes.com\/glossary\/ropinirole\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Ropinirole - Definition of Ropinirole\" \/>\n<meta property=\"og:description\" content=\"A dopamine agonist drug indicated for the treatment of the signs and symptoms of idiopathic parkinson\u2019s disease and of moderate to severe primary restless legs syndrome. Marketed under the brand name requip.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.healthbenefitstimes.com\/glossary\/ropinirole\/\" \/>\n<meta property=\"og:site_name\" content=\"Glossary\" \/>\n<meta property=\"article:published_time\" content=\"2020-07-16T09:54:24+00:00\" \/>\n<meta name=\"author\" content=\"Glossary\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Glossary\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/ropinirole\/\",\"url\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/ropinirole\/\",\"name\":\"Ropinirole - Definition of Ropinirole\",\"isPartOf\":{\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#website\"},\"datePublished\":\"2020-07-16T09:54:24+00:00\",\"dateModified\":\"2020-07-16T09:54:24+00:00\",\"author\":{\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5\"},\"description\":\"A dopamine agonist drug indicated for the treatment of the signs and symptoms of idiopathic parkinson\u2019s disease and of moderate to severe primary restless legs syndrome. Marketed under the brand name requip.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/ropinirole\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.healthbenefitstimes.com\/glossary\/ropinirole\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/ropinirole\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Ropinirole\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#website\",\"url\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/\",\"name\":\"Glossary\",\"description\":\"Difinitions\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5\",\"name\":\"Glossary\",\"url\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/author\/adminglossary\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Ropinirole - Definition of Ropinirole","description":"A dopamine agonist drug indicated for the treatment of the signs and symptoms of idiopathic parkinson\u2019s disease and of moderate to severe primary restless legs syndrome. Marketed under the brand name requip.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.healthbenefitstimes.com\/glossary\/ropinirole\/","og_locale":"en_US","og_type":"article","og_title":"Ropinirole - Definition of Ropinirole","og_description":"A dopamine agonist drug indicated for the treatment of the signs and symptoms of idiopathic parkinson\u2019s disease and of moderate to severe primary restless legs syndrome. Marketed under the brand name requip.","og_url":"https:\/\/www.healthbenefitstimes.com\/glossary\/ropinirole\/","og_site_name":"Glossary","article_published_time":"2020-07-16T09:54:24+00:00","author":"Glossary","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Glossary"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/ropinirole\/","url":"https:\/\/www.healthbenefitstimes.com\/glossary\/ropinirole\/","name":"Ropinirole - Definition of Ropinirole","isPartOf":{"@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#website"},"datePublished":"2020-07-16T09:54:24+00:00","dateModified":"2020-07-16T09:54:24+00:00","author":{"@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5"},"description":"A dopamine agonist drug indicated for the treatment of the signs and symptoms of idiopathic parkinson\u2019s disease and of moderate to severe primary restless legs syndrome. Marketed under the brand name requip.","breadcrumb":{"@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/ropinirole\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.healthbenefitstimes.com\/glossary\/ropinirole\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/ropinirole\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.healthbenefitstimes.com\/glossary\/"},{"@type":"ListItem","position":2,"name":"Ropinirole"}]},{"@type":"WebSite","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#website","url":"https:\/\/www.healthbenefitstimes.com\/glossary\/","name":"Glossary","description":"Difinitions","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.healthbenefitstimes.com\/glossary\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5","name":"Glossary","url":"https:\/\/www.healthbenefitstimes.com\/glossary\/author\/adminglossary\/"}]}},"_links":{"self":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts\/29232","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/comments?post=29232"}],"version-history":[{"count":1,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts\/29232\/revisions"}],"predecessor-version":[{"id":29233,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts\/29232\/revisions\/29233"}],"wp:attachment":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/media?parent=29232"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/categories?post=29232"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/tags?post=29232"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}